Computer-assisted Total Knee Arthroplasty (TKA) With Zimmer LPS Flex Knee System

NCT ID: NCT00300326

Last Updated: 2016-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine clinical outcomes and biomechanical gait performance of patients who receive the Zimmer Legacy® LPS Flex Knee system using a computer-assisted surgical technique. This study will provide evidence as to whether there are differences between the two surgical procedures with respect to complications such as infection and dislocations, rate and level of functional recovery, blood loss, operating time, degree of radiographic correction and quality and duration of post-operative pain and stiffness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to determine the clinical outcomes and biomechanical gait performance of patients who receive the Zimmer Legacy® LPS Flex Knee system using a computer-assisted surgical technique. Pre and post-operative clinical and gait variables will be compared within the computer-assisted group. These same comparisons will also be made between the computer-assisted surgical group and a conventional surgical group who receive the same knee implant. This study will further provide evidence as to whether there are differences between the two surgical procedures with respect to complications such as infection and dislocations, rate and level of functional recovery, blood loss, operating time, degree of radiographic correction and quality and duration of post-operative pain and stiffness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Using the same knee implant with a conventional surgical technique.

Group Type NO_INTERVENTION

No interventions assigned to this group

2

Using the same knee implant using a computer-assist surgery group is the comparator

Group Type ACTIVE_COMPARATOR

Computer assist

Intervention Type PROCEDURE

same implant using a computer-assisted surgical technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computer assist

same implant using a computer-assisted surgical technique.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 50-80

* undergoing primary total knee arthroplasty
* femoral tibial varus \< 7 degrees
* no previous joint infections
* anteriorcruciate ligament intact
* clinically significant patellofemoral or osteoarthritic degeneration

Exclusion Criteria

* active articular infections
* significant concurrent ipsilateral hip osteoarthritis
* chronic pain syndrome requiring medications for control
* history of chemical addiction
* significant spinal stenosis, chronic back pain, sciatica
* patients who are unlikely to comply with, participate in or return for follow-up visits as described in the protocol
* osteomyelitis, septicemia or other infections that may spread to other areas of the body
* highly communicable diseases, immuno-compromising conditions and/or that may limit follow-up (eg. AIDS, active tuberculosis, venereal disease, active hepatitis, neoplastic disease)
* diabetic neuropathy
* skeletal immaturity
* decreased mental comprehension and literacy
* pregnancy
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role collaborator

Queen's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. John Rudan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Rudan, MD

Role: PRINCIPAL_INVESTIGATOR

Queen's University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SURG-130-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Comparative Study of Knee Systems
NCT01331278 COMPLETED PHASE4
Robotic Assisted TKA
NCT06062615 COMPLETED NA